Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.

被引：0
|
作者：
Font, A
Esteban, E
Carles, J
Climent, MA
Gonzalez-Larriba, JL
Berrocal, A
Bellmunt, J
Garcia-Ribas, I
Marfa, X
Fabregat, X
机构：
[1] Hosp Germans Trias & Pujol, Badalona, Spain
[2] Hosp Gen Asturias, E-33006 Oviedo, Spain
[3] Hosp Mar, Barcelona, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Gen Hosp, Valencia, Spain
[7] Hosp Gen Valle Hebron, Barcelona, Spain
[8] Eli Lilly & Co, Alcobendas, Spain
[9] Sanofi Sinthelabo, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4544
引用
收藏
页码：392S / 392S
页数：1
相关论文
共 50 条
  • [31] Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: A multicenter phase II study
    Androulakis, N
    Syrigos, K
    Polyzos, A
    Aravantinos, G
    Stathopoulos, GP
    Ziras, N
    Mallas, K
    Vamvakas, L
    Georgoulis, V
    [J]. CANCER INVESTIGATION, 2005, 23 (01) : 9 - 12
  • [32] A Phase II Study of Gemcitabine and Irinotecan in Patients With Locally Advanced or Metastatic Bladder Cancer
    Chaudhary, Uzair B.
    Verma, Nitin
    Keane, Thomas
    Gudena, Vinay
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (02): : 188 - 193
  • [33] Gemcitabine and oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer
    All, M.
    Carillio, G.
    Mazzola, A.
    Bagnato, S.
    Di Leo, M. G.
    Fallica, G.
    Anna, Aiello R.
    Chiarenza, M.
    Caruso, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
  • [34] Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
    Ishikawa, Takeshi
    Kokura, Satoshi
    Sakamoto, Naoyuki
    Ando, Takashi
    Imamoto, Eiko
    Hattori, Takeshi
    Oyamada, Hirokazu
    Yoshinami, Naomi
    Sakamoto, Masafumi
    Kitagawa, Kazutomo
    Okumura, Yoko
    Yoshida, Naohisa
    Kamada, Kazuhiro
    Katada, Kazuhiro
    Uchiyama, Kazuhiko
    Handa, Osamu
    Takagi, Tomohisa
    Yasuda, Hiroaki
    Sakagami, Junichi
    Konishi, Hideyuki
    Yagi, Nobuaki
    Naito, Yuji
    Yoshikawa, Toshikazu
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2012, 28 (07) : 597 - 604
  • [35] A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer
    Yun, Jina
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Soong Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hoe Sook
    Choi, Hyun Jong
    Moon, Jong Ho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer
    Gyeong-Won Lee
    Hye Jung Kim
    Ji-Hyun Ju
    Seok-Hyun Kim
    Hoon Gu Kim
    Tae Hyo Kim
    Hyun Jin Kim
    Chi-Young Jeong
    Jung Hun Kang
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 64
  • [37] A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumbab for Locally Advanced or Metastatic Biliary Tract Cancer
    Iyer, Renuka V.
    Pokuri, Venkata K.
    Groman, Adrienne
    Ma, Wen W.
    Malhotra, Usha
    Iancu, Dan M.
    Grande, Catherine
    Saab, Tanios B.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 649 - 655
  • [38] Phase II trial of S-1 in combination with gemcitabine for chemo-na⟨ve patients with locally advanced or metastatic pancreatic cancer
    Lee, Gyeong-Won
    Kim, Hye Jung
    Ju, Ji-Hyun
    Kim, Seok-Hyun
    Kim, Hoon Gu
    Kim, Tae Hyo
    Kim, Hyun Jin
    Jeong, Chi-Young
    Kang, Jung Hun
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 707 - 713
  • [39] A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer
    Woo, Sang Myung
    Lee, Sang Hyub
    Yoo, Ji Won
    Yang, Ki Young
    Seo, Jung Gyun
    Park, Joo Kyung
    Hwang, Jin-Hyeok
    Lee, Woo Jin
    Ryu, Ji Kon
    Kim, Yong-Tae
    Yoon, Yong Bum
    [J]. GUT AND LIVER, 2013, 7 (05) : 594 - 598
  • [40] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
    Kyung Hee Lee
    Min Kyoung Kim
    Yeol Hong Kim
    Baek Yeol Ryoo
    Ho Yeong Lim
    Hong Suk Song
    Hoon Kyo Kim
    Myung Ah Lee
    Seock Ah Im
    Heung Moon Chang
    Jae Yong Cho
    Dae Young Zang
    Bong Seog Kim
    Jun Suk Kim
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 64 : 317 - 325
12345